← Evidence map

ArticleReports (MDPI)2026

Subacute-Onset Anemia Following COVID-19 Vaccine Combination with ChAdOx (AstraZeneca) and BNT162b2 (BioNTech, Pfizer)-A Case Report.

Konstantina Salveridou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Subacute-Onset Anemia Following COVID-19 Vaccine Combination with ChAdOx (AstraZeneca) and BNT162b2 (BioNTech, Pfizer)-A Case Report. | OpenQuestion